Nelson Dusetti, INSERM Research Director at CRCM and Institut Paoli-Calmettes, shared on LinkedIn: “From pancreatic cancer ...

India Accounts for Just 1.41% of Global Lung Cancer Clinical Trials Over 20 Years / Arjun Kumar, Atharva Salunke, cancer, ...

Happy to Share Our Review on Prostate Cancer Risk Factors and Prevention With Giorgio Gandaglia / Adam B. Weiner, Alberto ...

Are ADCs as Safe for Older Adults With Breast Cancer? / Aditya Bardia, Alexis A LeVee, Alexis LeVee, Arman Niknafs, Breast ...

Bravo Brian Rini on Advancing Biomarker-Driven Treatment Selection in RCC / Anupama Reddy, Brian Rini, cancer, kidney cancer, ...

What ESMO ESCAT v2 Means for Precision Oncology / A. El Helali, A. Stenzinger, Annals of Oncology, Avishek Roy, C. Cardone, C ...

Less Monitoring, More Freedom? The Future of CML Care / Asciminib, BCR::ABL1, cancer, chronic myeloid leukemia, CML, CML ...

A Remarkable Outcome in Penta-Refractory Myeloma After Just One Dose of Belantamab / Al-Ola A Abdallah, cancer, Myeloma, ...

Honored to Represent Pfizer at ESMO for the 12th Consecutive Year / Atul Bhalla, cancer, ESMO, esmo 2026, ESMO 26, OncoDaily, ...

Carmen Monge-Montero Reflects on Patient Advocacy and Meaningful Connections at ESMO 2026 / Alejandra Toro, cancer, cancer ...

Proud to Present Promising XMab819 Results at ESMO 2026 / Adanma Ayanambakkam, Benjamin Garmezy, cancer, Christopher Hoimes, ...

What Was Our Team on Stage With? / Armando Orlandi, cancer, esmo 2026, ESMO 26, Giampaolo Tortora, OncoDaily, Oncology ...